CDTX vs MTCH · rev $1.3M vs P/E 13, rev $3.48B
Cidara Therapeutics Inc (CDTX) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
CDTX currently screens at market cap $6.96B. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the CDTX and MTCH stock pages for the full models.
Not investment advice.